Sleep Disorders News

In patients with moderate to severe obstructive sleep apnea, carbonic anhydrase inhibition with sulthiame was safe and improved outcomes in the short term, researchers reported at the European Respiratory Society International Congress.

A new clinical trial is underway to evaluate the long-term effectiveness of inspiratory muscle training to reduce blood pressure and improve cardiovascular health in adults with obstructive sleep apnea.

In patients with idiopathic pulmonary fibrosis, multimorbidity was prevalent and comorbidity clusters may represent phenotypes with distinct profiles and characteristics, researchers reported in Respiratory Medicine.

Obstructive sleep apnea can predispose a person to hyperglycemia and even type 2 diabetes, yet data show continuous positive airway pressure therapy does not improve markers of glucose dysregulation, according to a speaker.

The Healio Editors have compiled a list of the most-read news in pulmonology posted in August.

Experts said they developed new guidance that stakeholders can use to design a shift work duration that “effectively balances the need to meet operational demands with the need to manage fatigue-related risks.”

According to a scientific statement published in the Journal of the American Heart Association, obstructive sleep apnea is common among children and adolescents and may be associated with BP and heart structure.

The FDA approved a new indication for Xywav for the management of idiopathic hypersomnia in adults, according to a press release from the agency.

More physical activity and less time spent sedentary were associated with a lower incidence of obstructive sleep apnea, according to new results published in the European Respiratory Journal.

Obstructive sleep apnea is a significant risk factor for all-cause sudden death and cardiovascular mortality, according to findings published in BMJ Open Respiratory Research.